期刊文献+

新辅助化疗联合保肢手术治疗四肢骨肉瘤患者的疗效研究 被引量:7

Efficacy of Neoadjuvant Chemotherapy and Limb Salvage Surgery for Limb Osteosarcoma
在线阅读 下载PDF
导出
摘要 目的研究新辅助化疗联合保肢手术治疗四肢骨肉瘤患者的疗效。方法选取132例四肢骨肉瘤进行保肢术,根据治疗方法分为观察组和对照组。对照组64例患者采用保肢手术+术后辅助化疗方案进行治疗,观察组68例患者采用新辅助化疗+保肢手术+术后辅助化疗方案进行治疗。对比两组患者治疗半年后肢体功能、化疗期间毒性反应、3年生存率。结果两组患者化疗期间胃肠道反应、血小板减少、白细胞下降、肝功能损害、末梢神经毒性、肾功能损害发生率比较差异均无统计学意义(P>0.05)。观察组患者肢体功能Enneking评分高于对照组患者,比较两组间差异具有统计学意义(P<0.05)。观察组患者优良率高于对照组患者,两组比较差异无统计学意义(P>0.05)。化疗3年后,观察组患者的平均生存时间显著长于对照组患者,两组比较差异具有统计学意义(P<0.05)。结论较单纯保肢手术治疗四肢骨肉瘤,新辅助化疗联合保肢手术能够改善患者肢体功能,延长术后生存时间和远期生存率。 Objective To study the efficacy of neoadjuvant chemotherapy and limb salvage surgery for limb osteosarcoma. Methods 132 cases of limb osteosarcoma treated with limb salvage surgery,according to surgical methods,were divided into the observation group and the control group. The control group were treated with limb salvagesurgery plus adjuvant chemotherapy,the observation group( n = 68) were treated with neoadjuvant chemotherapy and limb salvage surgery plus adjuvant chemotherapy. Limb function 6 months after operation,toxicity during chemotherapy,and 3-year survival rate of the 2 groups were compared.Results There had no significant difference between the 2 groups during chemotherapy in gastrointestinal reactions,thrombocytopenia,leukopenia,hepatic dysfunction,peripheral neurotoxicity,and incidence of renal impairment( P > 0. 05). Limb function Enneking score in the observation group was higher than that of the control group,there had significant difference( P < 0. 05). Excellent rate in the observation group was higher than that of the control group,there had no significant difference( P > 0. 05). 3years after chemotherapy,the average survival time in the observation group was longer than that of the control group,there had significant difference( P < 0. 05). Conclusion Compared with simple limb salvage surgery,neoadjuvant chemotherapy combined with limb salvage surgery for limb osteosarcoma can improve physical function,prolong survival time and increase long-term survival rate.
作者 高强 李晓锋
出处 《实用癌症杂志》 2015年第6期821-823,827,共4页 The Practical Journal of Cancer
关键词 新辅助化疗 保肢手术 四肢骨肉瘤 Neoadjuvant chemotherapy Limb osteosarcoma Limb bone sarcomas
  • 相关文献

参考文献9

二级参考文献71

共引文献36

同被引文献54

  • 1喻紫晨,肖兢,徐海声.四肢骨肉瘤患者的治疗及预后分析[J].实用癌症杂志,2014,29(2):199-201. 被引量:17
  • 2赵亚恒,冯和林,郑丽华,贾志峰,冯建刚.骨肉瘤发病机制的研究进展[J].肿瘤防治研究,2014,41(3):283-286. 被引量:25
  • 3Jiang F, Shi Y, Li GJ, et al. A meta-analysis of limb-salvage versus amputation in the treatment of patients with Ennekingdouble daggerU pathologic fracture osteosarcoma[ J]. Indian J Cancer,2015,51 (Suppl 2) :e21-24.
  • 4Glasser DB, Lane JM. Stage IIB osteogenic sarcoma [J]. Clin Orthop Relat Res, 1991,9 (270) :29-39.
  • 5胥少汀,葛宝丰,徐印坎.主编.实用骨科学[M].北京:人民军医出版社,1997.7.
  • 6Guder WK, Hardes J, Gosheger G, et al. Osteosarcoma and chondmsar- coma of the pelvis and lower extremities [ J ]. Chirurg, 2015,86 ( 10 ) : 993-1003.
  • 7Chandrasekar CR, Grimer RJ, Carter SR, et al. Outcome of pathologic fractures of the proximal femur in nonosteogenic primary bone sarcoma [J]. Eur J Surg Oncol,2011,37(6) :532-536.
  • 8Haase SC. Treatment of pathologic fractures[ J ]. Hand Clin,2013, 29 (4) :579-584.
  • 9Scully SP, Ghert MA,Zurakowski D, et al. Pathologic fracture in os- teosarcoma:proguostic importance and treatment implications [ J ]. J Bone Joint Surg Am,2002,84-A(1 ) :49-57.
  • 10Ferguson PC, MeLaughlin CE, Griffin AM,et at. Clinical and function- al outcomes of patients with a pathologic fracture in high-grade osteo- sarcoma[ J]. J Surg Oncol,2010,102(2) : 120-124.

引证文献7

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部